Apergy (APY) PT Lowered to $29 at BofA/Merrill Lynch
Tweet
Share
E-mailGet Alerts APY Hot Sheet
Price: $10.34 --0%
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Rating Summary:
9 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 10 | New: 5
Join SI Premium – FREE
BofA/Merrill Lynch analyst Chase Mulvehill lowered the price target on Apergy (NYSE: APY) to $29.00 (from $31.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $85 at Scotiabank
- Watsco (WSO) PT Raised to $460 at Baird
- Impinj Inc (PI) PT Raised to $145 at Roth/MKM
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
